A Study of PRT-201 Administered Immediately After Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 151 participants.

Also called NCT01305824

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 151 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01305824
Other papers using this trial's data
  • Human type I pancreatic elastase treatment of arteriovenous fistulas in patients with chronic kidney disease Journal of vascular surgery, 2014-08 DOI, PubMed 24684771

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01305824. Randomized; quadruple masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2012-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of PRT-201 Administered Immediately After Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Intervention (Drug)
PRT-201
Intervention (Drug)
Placebo
Intervention (Drug)
PRT-201
Lead sponsor
Proteon Therapeutics (class: industry)

Record details

Record id
cardio:ct-nct01305824
Content hash
a4533f384607e4873672aafa769533ffda5523c9a46415cf080df3a1fe50603b